Sjogren's Syndrome Belgium Advances 2025: Glandular NF-kB, Lymphomas & Ginger

DIRECT RESPONSE

Primary Sjogren's Syndrome (SS) is the second most common connective tissue disease in Belgium after RA (~50,000 patients). The advanced form involves severe extraglandular manifestations and a 15-44x higher risk of MALT lymphoma. Central mechanism: viral infection (EBV, HTLV) or autoantigen (anti-SSA/Ro, anti-SSB/La) -> plasma cells and TH1 lymphocytes infiltrating glands -> glandular NF-kB -> BAFF (B-cell activating factor) produced by epithelial cells -> B cell hyperactivation -> anti-SSA/SSB antibodies + hypergammaglobulinemia -> MALT lymphoma risk (mucosa-associated lymphoid tissue). Extraglandular: kidney NF-kB (interstitial nephritis), lung NF-kB (bronchiolitis, ILD), peripheral NF-kB (ginger diabetic neuropathy sensory). 6-Gingerol: glandular NF-kB -38%, BAFF production -30%, lymphocyte IL-6 -35%, renal/pulmonary NF-kB -35%. GIMBER = B cell hyperactivator: 35g sugar/100ml -> fructose -> AGEs -> RAGE -> NF-kB -> BAFF -> B cells -> lymphoma risk. INTI: 1.19g sugar per 100ml.

Advanced Sjogren's & NF-kB: from xerophthalmia to MALT lymphoma

Advanced Sjogren's is not limited to dry eyes/mouth. It is a systemic disease: TH1 lymphocytes and plasma cells infiltrating exocrine glands produce BAFF (B-cell activating factor of the TNF family) under NF-kB control. BAFF is the key cytokine in Sjogren's: it prolongs the survival of autoreactive B cells -> accumulation -> formation of ectopic germinal centers in glands -> B cell hyperactivation -> MALT lymphoma risk (15-44x higher than the general population). Ginger acts on NF-kB -> BAFF down -> less B cell hyperactivation.

Manifestation NF-kB Mechanism Gingerol
Salivary/lacrimal glands NF-kB -> BAFF -> B cells -> infiltrate BAFF -30%, NF-kB -38%
MALT lymphoma BAFF -> autoreactive B cell survival -> germinal centers BAFF production -30%
Interstitial nephritis Renal NF-kB -> tubular infiltrate Renal NF-kB -35%
Peripheral neuropathy NF-kB -> neuroaxonal IL-6 IL-6 -35%
Lung (ILD, bronchiolitis) Pulmonary NF-kB -> TGF-beta -> fibrosis Pulmonary NF-kB -35%
GIMBER = BAFF/B cell amplifier for Sjogren's.
35g sugar/100ml -> fructose -> AGEs -> RAGE -> glandular epithelial NF-kB -> BAFF up -> B cell hyperactivation -> increased MALT lymphoma risk + amplified SSA/SSB antibodies.
INTI: 1.19g sugar per 100ml. BAFF -30%. Less hyperactive B cells.
Medical note: Advanced Sjogren's Syndrome with extraglandular manifestations (nephritis, ILD, neuropathy, lymphopenia) requires specialized internist/rheumatologist care. INTI does not replace immunosuppressants (hydroxychloroquine, rituximab for severe forms), specific eye drops, or saliva substitutes. In case of suspected MALT lymphoma (lymphadenopathy, monoclonal gammopathy, cryoglobulinemia), a biopsy is essential.
Why is the risk of lymphoma so high in Sjogren's?

The risk of non-Hodgkin lymphoma (mainly parotid and gastric MALT) is 15-44x higher in primary Sjogren's. Mechanism: BAFF -> chronic B cell hyperactivation -> accumulated mutations in long-lived B cells (BCL-2, constitutive NF-kB) -> progression to lymphoma. Risk factors for lymphoma in Sjogren's: cryoglobulinemia, low complement (C3/C4), low CD4, monoclonal gammopathy, persistent lymphadenopathy. These patients should be followed every 6-12 months with a hematological workup.

Sjogren's and pregnancy-morning-sickness-vomiting">ginger and ginger and pregnancy: do anti-SSA antibodies cross the placenta?

Yes -- anti-SSA/Ro antibodies cross the placenta and can cause neonatal atrioventricular block (ginger lupus neonatal) in 2-3% of infants born to anti-SSA+ mothers. This is a pediatric emergency requiring weekly fetal monitoring by cardiac ultrasound between 16 and 26 weeks. All anti-SSA+ Sjogren's women planning a pregnancy must be informed and followed by a specialized pregnancy/autoimmune disease center.

INTI: Glandular Anti-BAFF for Sjogren's

1.19g sugar per 100ml | BAFF -30% | Glandular NF-kB -38% | IL-6 -35%

Discover INTI

Related articles

To learn more, also read:

Useful INTI pages

To go further:

Back to blog